Surgical Premature Menopause Tied to Risk for Muscle Disorders
By Lori Solomon HealthDay Reporter
TUESDAY, May 7, 2024 -- Women experiencing surgical premature menopause (PM) have a higher likelihood of developing musculoskeletal disorders, according to a study published online April 30 in Menopause.
María S. Vallejo, M.D., from Universidad de Chile in Santiago, and colleagues compared muscle disorders among women with PM (176) or normal age of menopause (NAM; 468).
The researchers found that women who had PM experienced significantly more musculoskeletal discomfort (33.5 versus 20.9 percent) and a significantly higher likelihood of sarcopenia (35.2 versus 19.9 percent) versus women with NAM. Surgical PM showed an even significantly higher prevalence of severe musculoskeletal discomfort (46.7 versus 29.3 percent) and a higher likelihood of sarcopenia (45.0 versus 27.6 percent) versus women who had NAM. Spontaneous PM was not associated with higher odds of musculoskeletal discomfort or sarcopenia when adjusting for age, body mass index, menopausal hormone therapy use, physical activity, education, cigarette consumption, use of antidepressants, sexual activity, comorbidities, and having a partner. Women who had surgical PM were more likely to experience musculoskeletal discomforts (odds ratio, 2.26) and sarcopenia (odds ratio, 2.05) versus women with NAM.
"This study highlights the potential long-term musculoskeletal effects of premature surgical menopause, which causes a more abrupt and complete loss of ovarian hormones, including estrogen and testosterone, than natural menopause," Stephanie Faubion, M.D., medical director of The Menopause Society, said in a statement. "The use of hormone therapy until the natural age of menopause has the potential to mitigate some of the adverse long-term effects of early estrogen loss."
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
More Physical Activity Tied to Higher Odds of Hot Flashes
FRIDAY, May 31, 2024 -- Increases in physical activity increase the odds of menopause-related hot flashes, according to a study published online May 28 in Menopause. Sarah...
ASCO: Conjugated Equine Estrogen May Increase Risk for Ovarian Cancer
TUESDAY, May 28, 2024 -- Conjugated equine estrogen (CEE) taken alone for menopause may increase the risk for developing and dying from ovarian cancer, according to a study...
Fezolinetant Safe, Effective for Moderate-to-Severe Menopause Hot Flashes
MONDAY, May 20, 2024 -- Fezolinetant is safe and effective for moderate-to-severe vasomotor symptoms (VMS), according to a study presented at the annual European Congress of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.